Last $0.02 USD
Change Today 0.00 / 0.00%
Volume 750.0
LTUS On Other Exchanges
Symbol
Exchange
OTC US
As of 5:10 PM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

lotus pharmaceuticals inc (LTUS) Snapshot

Open
$0.01
Previous Close
$0.02
Day High
$0.02
Day Low
$0.01
52 Week High
12/4/13 - $0.03
52 Week Low
10/6/14 - $0.0070
Market Cap
422.8K
Average Volume 10 Days
672.0
EPS TTM
$0.21
Shares Outstanding
27.8M
EX-Date
--
P/E TM
0.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for LOTUS PHARMACEUTICALS INC (LTUS)

Related News

No related news articles were found.

lotus pharmaceuticals inc (LTUS) Related Businessweek News

No Related Businessweek News Found

lotus pharmaceuticals inc (LTUS) Details

Lotus Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceuticals in the People’s Republic of China. The company markets valsartan capsules under the Maixin name to treat hypertension; eye drops under the Muxin name to treat glaucoma; and Octreotide Acetate Injection solution under the Yipubishan name for treating gastric ulcers. It also offers Junxin branded Levofloxacin, an anti-bacterial drug for the treatment of mild, moderate, and severe infections caused by susceptible trains of the designated microorganisms in the conditions such as acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, complicated and uncomplicated skin and skin structure infections, complicated and uncomplicated urinary tract infections, and acute pyelonephritis; and Nicergoline for Injection, an a-receptor blockage nerve system blood-brain medicine. The company's products under development include R-Bambuterol-Class 1 for the treatment of asthma; Gliclazide-controlled release tablets for the treatment of diabetes; Isosorbide Mononitrate-tablets for the treatment of cardiovascular-coronary artery; Verapamil Hydrochloride tablets for the treatment of cardiovascular-irregular angina; and Lovastatin tablets, Valsartan-controlled release tablets, and Hawthorn Flavonoids tablets for the treatment of cardiovascular-hyperlipemia. It also involves in retailing Western and traditional Chinese medications, and medical treatment equipment through 10 retail pharmacy locations; performing research and development, and lab testing projects for third parties; and leasing retail space to licensed physicians, and merchants in the retail pharmacies. The company sells its products through a nationwide sales network to hospitals, clinics, and drugs stores. Lotus Pharmaceuticals, Inc. is based in Beijing, the People’s Republic of China.

233 Employees
Last Reported Date: 03/28/11

lotus pharmaceuticals inc (LTUS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LTUS:US $0.02 USD 0.00

LTUS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LTUS.
View Industry Companies
 

Industry Analysis

LTUS

Industry Average

Valuation LTUS Industry Range
Price/Earnings 0.2x
Price/Sales 0.0x
Price/Book 0.0x
Price/Cash Flow 0.2x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LOTUS PHARMACEUTICALS INC, please visit www.lotuspharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.